Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 May;28(3):191-201.
doi: 10.3109/08820538.2013.771198.

Systematic review of educational interventions to improve glaucoma medication adherence

Paula Anne Newman-Casey  1 , Jennifer S Weizer, Michele Heisler, Paul P Lee, Joshua D Stein
Affiliations

Systematic review of educational interventions to improve glaucoma medication adherence

Paula Anne Newman-Casey et al. Semin Ophthalmol. 2013 May.

Abstract

Adherence to prescribed glaucoma medications is often poor, and proper adherence can be challenging for patients. We systematically reviewed the literature and identified eight studies using educational interventions to improve glaucoma medication adherence. Overall, five of the eight studies found that educational interventions lead to a significant improvement in medication adherence, and two additional studies found a trend towards improvement. Using information from this systematic review and Health Behavior Theory, we constructed a conceptual framework to illustrate how counseling and education can improve glaucoma medication adherence. More rigorous studies grounded in Health Behavior Theory with adequately powered samples and longer follow-up are needed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Conceptual Model of Glaucoma Medication Adherence
See this image and copyright information in PMC

References

    1. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. American journal of ophthalmology. 2000;130:429–440. - PubMed
    1. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Archives of ophthalmology. 2003;121:48–56. - PubMed
    1. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Archives of ophthalmology. 2002;120:701–713. discussion 829-730. - PubMed
    1. Stewart WC, Chorak RP, Hunt HH, Sethuraman G. Factors associated with visual loss in patients with advanced glaucomatous changes in the optic nerve head. American journal of ophthalmology. 1993;116:176–181. - PubMed
    1. Rossi GC, Pasinetti GM, Scudeller L, Radaelli R, Bianchi PE. Do adherence rates and glaucomatous visual field progression correlate? European journal of ophthalmology. 2011;21:410–414. - PubMed

Publication types

MeSH terms

Substances